Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Guardant Health, Inc. - Common Stock
(NQ:
GH
)
114.75
-2.53 (-2.16%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Guardant Health, Inc. - Common Stock
< Previous
1
2
...
13
14
15
16
17
18
19
20
Next >
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2022
↗
October 06, 2022
Upgrades
Via
Benzinga
Netflix, Biogen And Other Big Gainers From Wednesday
↗
September 29, 2022
U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Analyst Ratings for Guardant Health
↗
August 25, 2022
Within the last quarter, Guardant Health (NASDAQ:GH) has observed the following analyst ratings:
Via
Benzinga
Recap: Guardant Health Q2 Earnings
↗
August 04, 2022
Guardant Health (NASDAQ:GH) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:03 PM. Here's what investors need to know about the announcement.
Via
Benzinga
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
↗
September 27, 2022
Via
Benzinga
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
↗
September 23, 2022
The World Health Organization (WHO) warned that it struggles to identify and
Via
Benzinga
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
↗
September 14, 2022
Via
Benzinga
Biden Administration Pushes 'Cancer Moonshot' Initiative: Report
↗
September 13, 2022
President Joe Biden channeled John F. Kennedy on the 60th anniversary of the former President's moonshot speech, highlighting the Biden administration's efforts to "end cancer as we know it." The...
Via
Benzinga
Guardant Health Introduces GuardantINFINITY™ Smart Liquid Biopsy for Research Use to Help Bring New Cancer Therapies to Patients Sooner
September 09, 2022
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to showcase new data at ESMO 2022 demonstrating utility of its portfolio of blood tests for advanced-stage cancer patients
September 06, 2022
From
Guardant Health, Inc.
Via
Business Wire
Lululemon, Smartsheet, Okta, And Other Big Gainers From Friday
↗
September 06, 2022
U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Friday. Here is the list of some big stocks moving higher in the previous session.
Via
Benzinga
Guardant Health Expands Strategic Collaboration With Merck KGaA, Darmstadt, Germany, to Help Accelerate Development of Precision Oncology Therapeutics
August 31, 2022
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health to Participate in the Morgan Stanley Global Healthcare Conference
August 29, 2022
From
Guardant Health, Inc.
Via
Business Wire
No More Free COVID-19 At-Home Tests, Federal Government Says
↗
August 29, 2022
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au
Via
Benzinga
Why Micro Focus International Is Trading Higher By Around 94%; Here Are 28 Stocks Moving Premarket
↗
August 26, 2022
Gainers
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
↗
August 25, 2022
Upgrades
Via
Benzinga
Guardant Health's Return On Capital Employed Insights
↗
August 23, 2022
Benzinga Pro data, Guardant Health (NASDAQ:GH) reported Q2 sales of $109.14 million. Earnings fell to a loss of $229.43 million, resulting in a 86.18% decrease from last quarter.
Via
Benzinga
Guardant Health Expands Use of Guardant Reveal™ Liquid Biopsy Test for Residual Disease Detection and Recurrence Monitoring to Include Early-Stage Breast and Lung Cancers
August 15, 2022
From
Guardant Health, Inc.
Via
Business Wire
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
↗
August 12, 2022
Via
Benzinga
Daiichi-AstraZeneca's Flagship Cancer Drug Scores FDA Approval For Lung Cancer Harboring HER2 Mutation
↗
August 12, 2022
Via
Benzinga
Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for Daiichi Sankyo and AstraZeneca’s ENHERTU® for Treatment of NSCLC Patients With Activating HER2 Mutations
August 12, 2022
From
Guardant Health, Inc.
Via
Business Wire
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
↗
August 10, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
Via
Benzinga
Guardant Health to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit Conference
August 08, 2022
From
Guardant Health, Inc.
Via
Business Wire
Uber Dumped By Large Shareholder As Billionaire's 'Vision' Suffers Investment Struggles
↗
August 08, 2022
After reporting one of its largest losses ever, SoftBank Group Corp (OTC: SFTBY) has turned to alternative methods to regain lost capital.
Via
Benzinga
Guardant Health and Blueprint Medicines present real-world data identifying EGFR C797X mutation as most common resistance mechanism to osimertinib therapy at IASLC 2022 World Conference on Lung Cancer
August 08, 2022
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Announces New Data from its Portfolio of Blood Tests and GuardantINFORM™ Real-World Clinical-Genomic Platform at IASLC 2022 World Conference on Lung Cancer
August 05, 2022
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Reports Second Quarter 2022 Financial Results
August 04, 2022
From
Guardant Health, Inc.
Via
Business Wire
Guardant Health Receives Medicare Coverage for Guardant Reveal™ Test
August 02, 2022
From
Guardant Health, Inc.
Via
Business Wire
5 Top Stocks Cathie Wood Bought This Week
↗
July 29, 2022
Despite a 50% YTD drawdown in ARKK, Cathie Wood has continued her purchases of high growth companies, such as TDOC and BILL stocks.
Via
InvestorPlace
Guardant Health to Report Second Quarter 2022 Financial Results on August 4, 2022
July 13, 2022
From
Guardant Health, Inc.
Via
Business Wire
< Previous
1
2
...
13
14
15
16
17
18
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
